ArticleClinical ophthalmology (Auckland, N.Z.)2025
Long-Term Efficacy of CRT, Lucid, Euclid, and IBright Orthokeratology Lenses in Controlling Myopia Progression in Children and Adolescents: A 36-Month Retrospective Cohort Study.
Article in Clinical ophthalmology (Auckland, N.Z.), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: This study aimed to compare the efficacy and safety of four types of orthokeratology (OK) lenses (CRT, Lucid, Euclid, and IBright) in controlling mild to moderate myopia progression among children and adolescents over 36 months. Methods: This retrospective study analyzed clinical records of 219 children (438 eyes) who wore OK lenses for 36 months. Clinical data for the four commonly used OK lenses were collected and analyzed using one-way analysis of variance (ANOVA) and Pearson's chi-squared test. Results: At baseline, no significant differences were observed among the four groups in terms of age, sex, spherical equivalent, corneal curvature, or corneal thickness (all P > 0.05). All OK lenses effectively controlled myopia progression over the observation period, with axial length changes not exceeding 1.0 mm. At the 36-month follow-up, the IBright group showed the largest flat keratometry (K1) curvature change at 3 months (-2.40 ± 0.97 D), while other groups showed no significant differences at subsequent time points. In terms of steep keratometry (K2) curvature, the Lucid group exhibited the largest change at 24 months (-3.07 ± 1.50 D), but no significant differences were observed among groups at other time points. Axial length changes showed no statistically significant differences among the four OK lenses across follow-up visits (P > 0.05). Subgroup analysis indicated greater axial elongation in children under 12 years old compared to those over 12 years. Among children with corneal thickness less than 530 μm, the CRT group demonstrated the largest K1 curvature change. The incidence of adverse events was comparable across groups (P > 0.05). Conclusion: All four OK lenses demonstrated comparable efficacy and safety in controlling myopia progression, providing effective treatment options for children and adolescents with mild to moderate myopia. However, differences in curvature changes and age-related effects warrant further attention.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.